Cipher Pharmaceuticals Inc (CPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 4,827 | 6,957 | 4,573 | 12,172 | 10,090 |
| Cost of Goods | 564 | 563 | 496 | 693 | 395 |
| Gross Profit | 4,263 | 6,394 | 4,077 | 11,479 | 9,695 |
| Operating Expenses | 3,194 | 3,545 | 3,453 | 3,561 | 3,443 |
| Operating Income | 1,069 | 2,849 | 624 | 7,918 | 6,252 |
| Interest Expense | 240 | 215 | 182 | 2,593 | 631 |
| Other Income | 84 | 208 | -1,534 | -78 | -445 |
| Pre-tax Income | 913 | 2,842 | -1,092 | 5,247 | 5,176 |
| Income Tax | 175 | 927 | -141 | 1,298 | 1,253 |
| Net Income Continuous | 738 | 1,915 | -951 | 3,949 | 3,923 |
| Net Income Discontinuous | -37 | 213 | -250 | -130 | -1,184 |
| Net Income | $701 | $2,128 | $-1,201 | $3,819 | $2,739 |
| EPS Basic Total Ops | 0.03 | 0.08 | -0.05 | 0.14 | 0.10 |
| EPS Basic Continuous Ops | 0.03 | 0.07 | -0.04 | 0.14 | 0.15 |
| EPS Basic Discontinuous Ops | 0.00 | 0.01 | -0.01 | 0.00 | -0.05 |
| EPS Diluted Total Ops | 0.03 | 0.08 | -0.05 | 0.14 | 0.10 |
| EPS Diluted Continuous Ops | 0.03 | 0.07 | -0.04 | 0.14 | 0.15 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.01 | -0.01 | -0.01 | -0.05 |
| EBITDA(a) | $1,334 | $3,222 | $-684 | $8,079 | $6,053 |